Medical Filtration Market

Report Code CH 9289
Published in Feb, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Medical Filtration Market by Material (Polyethersulfone; Polyvinylidenefluoride), Applications (Dialysis; Sterile Processing), Process Technology (Ultrafiltration; Microfiltration), Design/Process, End-Users & Region - Global Forecast to 2030

Overview

The global medical filtration market is projected to reach USD 9.35 billion by 2030 from USD 6.29 billion in 2024, at a CAGR of 6.8% during the forecast period. The growth in this market is driven by the increasing demand for high-quality filtration solutions supported by the increasing investments in healthcare infrastructure. The stringent regulatory standards by regulatory bodies such as the FDA and WHO are further fueling the growth of this market. Moreover, the changing patterns in the supply chain are boosting market growth by enhancing the accessibility and affordability of advanced filtration technologies across the healthcare sector.

Medical Filtration Market

Attractive Opportunities in the Medical Filtration Market

Asia Pacific

The market in the Asia Pacific is expected to witness high growth during the forecast period due to factors such as growing demand for high-quality filtration and increasing focus on infection control.

Market growth can be attributed to the growing demand for high-quality filtration solutions in hospitals & clinics.

Rising aging population and the increasing prevalence of chronic diseases in the Asia Pacific are driving the medical filtration market in the region.

The Asia Pacific medical filtration market is expected to be the fastest-growing during the forecast period.

Disposal of filters is a challenge to the growth of this market.

Global Medical Filtration Market Dynamics

DRIVER: Growing demand for high-quality filtration solutions

The growing demand for high-quality filtration solutions is a major driver for the medical filtration market, fueled by the increased demand for safety and efficacy standards in healthcare applications. This industry is primarily responsible for expanding the scope of using reliable filtration technologies to ensure the purity of fluids used in research and clinical settings. Effective filtration is also considered necessary to comply with stringent regulatory requirements by governing agencies like the FDA and EMA to ensure high-quality standards for medical products. Continuous improvement in filtration technologies, including nanofiltration and membrane systems, enhances the accuracy and efficiency levels, resulting in the development of solutions that can perform well in critical applications, such as IV infusions and sterile processing. Key companies have shifted their focus toward growth opportunities by innovating and developing specialized filtration products to cater to changing demands from healthcare providers and research institutes. The emphasis on sustainability is further aiding the development of environmentally friendly filtration solutions. Because of the global shift in habits toward sustainable practices, the continuing dependence of the health sector on patient safety and product integrity will ensure continuing growth in demand for high-quality medical filtration solutions.

RESTRAINT: High cost of advanced filtration systems

The high cost of filtration systems is a critical restraint for the medical filtration market. While these systems are necessary for ensuring the purity and safety of medical products, they place a large capital investment burden on organizations and may be very expensive to install in smaller healthcare facilities and research institutes. For example, the installation cost for microfiltration and ultrafiltration systems may lie between thousands of dollars and millions of dollars, depending on their complexity and volume. Additionally, maintenance and operational costs are also considerable, especially in areas where finances are already depleted. For example, critical area filters like those for operation rooms and ICUs must be serviced frequently to keep them performing at their best; these add to the operating costs. Specialized materials and technologies, such as high-performance membranes that can withstand a strict sterilization cycle, add up to these operating costs. Therefore, most prospective users may not invest in such advanced filtration systems on time, thus negatively affecting the market. Additionally, it may discourage facilities from implementing new systems if their integration proves complicated. It then presents a very difficult environment that calls for companies to be more innovative with solutions but still work under the budget constraints of the customer.

 

OPPORTUNITY: Advancements in filtration technologies

Advancements in filtration technologies provide significant opportunities to the medical filtration market through innovation and development for application in various fields across the healthcare industry. Developments in the last decade from material science fields have seen great progress in new technologies, such as the development of nanofiber and electrospun filters. The latter technology was the game changer, making filtration systems capture small particles and even pathogens more effectively. Such inventions have led to the development of filters that have better protection for airborne viruses, bacteria, and other contaminants to improve patient safety and infection control in health facilities.

Another opportunity derives from the increasing demand for green filtration technology. The drive toward a green material and a reusable or recyclable filter corresponds to global trends in sustainability in the healthcare sector. Medical filtration companies are increasingly looking at systems that cut energy consumption, reduce waste, and are environmentally friendly, thereby opening new markets, especially areas with increasing awareness of an environment-friendly environment. Moreover, stringent regulations in the healthcare sector have created a need for more sterilization and tighter contaminant control, which results in the demand for advanced filtration equipment to meet current standards.

CHALLENGES: Disposal of filters

One of the main challenges for the medical filtration market remains the disposal of the filters used in medical filtration. Above all, it is associated with the complexities of medical waste disposal. Filters, especially in sterile applications, become contaminated with hazardous materials such as pathogens and chemical residues, requiring careful handling and disposal to avoid health risks. It further complicates the process because a high volume of medical waste and stringent regulatory requirements for disposal are involved. Many existing disposal methods like incineration and landfilling have raised more environmental concerns due to possible emissions of toxic substances and the risk of contaminating soil and water sources. The lack of a standardized protocol to sort and recycle medical filters increases inefficiencies, which is the reason that escalates costs at healthcare facilities. Therefore, it is imperative that companies operating within the medical filtration market push sustainable disposal solutions both in relation to compliance and a reduction in their environmental impact. This situation has created a need for innovative approaches, such as recycling programs for reclaiming materials safely from used filters in healthcare settings without compromising public health. Addressing these challenges effectively is important for establishing a more sustainable medical filtration industry and improving the overall waste management practices in healthcare settings.

Global Medical Filtration Market Ecosystem Analysis

The medical filtration market ecosystem comprises raw material suppliers, manufacturers, distributors, and end users such as hospitals, diagnostic centers, and research institutes. The raw materials for manufacturing medical filtration include polymers and specialty chemicals. Raw material suppliers supply necessary materials for the manufacturing of medical filtrations. These materials should comply with strict regulatory standards for safety and biocompatibility. The raw materials are then processed by manufacturers into different forms of medical filtrations, which have a wide range of applications, such as dialysis, drug delivery, IV infusion, sterile filtration, and sterile processing. The distribution of the product is crucial for the delivery of products to healthcare providers for different medical applications. End users include hospitals, diagnostics centers, and research institutes, which use these filters for various filtration applications catering to the healthcare industry.

Medical Filtration Market
 

Dialysis accounts for the largest market share, by application, in the medical filtration market

Dialysis accounts for the largest market share of the medical filtration market, mainly due to the rising cases of chronic kidney disease and end-stage renal disease. The increasing global prevalence of kidney-related conditions, mainly attributed to the increasing cases of diabetes and hypertension—two leading risk factors for CKD—has led to an increased demand for dialysis treatments. Since dialysis filtration is the replacement of kidney function when the kidneys fail by removing waste and toxins from the blood, it is an inevitable necessity for patients with end-stage renal diseases.

Technological advancements in dialysis filtration systems have increased the efficiency of treatment, decreased complications, and improved comfort for patients, leading to its wide adoption, such as high-flux and low-flux membranes. The two major modalities, hemodialysis and peritoneal dialysis, depend on advanced filtration technologies for both safety and efficacy. The global aging population has increased the demand for them since older adults have been increasingly found to be at an increased risk of getting kidney diseases and complications. In addition, the growth in the number of dialysis centers, home-based dialysis options, and government initiatives that facilitate access to dialysis care have further driven the growth of the market. The other factor is the frequency of dialysis treatment. Since patients require a number of sessions per week, the service creates a fairly consistent demand in terms of requirements for consumable items such as filters, membranes, and cartridges, thus stabilizing its position in the market.

The ultrafiltration segment held the largest market share of the medical filtration market, by process technology, in terms of value

Ultrafiltration held the largest market share by process technology because it allows better efficiency with high versatility, coupled with the very critical application scope across several segments of health sciences. The mechanism of ultrafiltration involves the filtration of bacteria and viruses as well as other lethal pyrogens through semipermeable membranes while holding valuable proteins and other nutrients intact, which makes this choice appropriate for health and pharmaceutical streams. It finds applications in many critical operations like dialysis, blood purification, and preparation of intravenous fluids. Ultrafiltration is vital to remove excess fluid in the case of dialysis without letting go of electrolyte balance or other critical solutes, hence improving the efficacy of treatment. Ongoing innovations and advancements in membrane materials and designs have improved the efficiency and durability of ultrafiltration systems, thereby lowering the cost and making them available to both developed and emerging markets. The growing need for minimally invasive and highly effective treatments in the healthcare sector, combined with strict regulatory requirements for sterility and contamination control, has intensified the application of ultrafiltration in various healthcare facilities.

Asia Pacific is the fastest-growing region in the medical filtration market during the forecast period

The Asia Pacific is the fastest-growing market for medical filtration because of demographic, economic, and healthcare advances. The rapidly growing population, mainly in countries such as China, India, and countries in Southeast Asia, is also supporting the growth of the healthcare market in the region. The rising geriatric population facing chronic diseases like kidney disease, cardiovascular conditions, and diabetes are the biggest drivers for advanced medical filtration solutions in the region. The growing focus on infection control has significantly increased demand for sterility-based medical devices and filtration technologies to deliver contamination-free treatments without affecting the patient’s safety. Economic growth in the Asia Pacific has led to investment in healthcare infrastructure and the growth of medical services. The heavy investments by government and private sectors in healthcare and research facilities, especially in developing economies, are further boosting market growth.

Asia Pacific has remained the hub of drug manufacturing and clinical trials primarily due to cost advantages and the availability of a skilled workforce. The demand for ultrafiltration and microfiltration solutions in the drug formulation and sterile processing stages has increased. More recently, awareness of infection prevention and cross-contamination in healthcare has promoted the adoption of filtration technologies. Increased healthcare spending, advances in medical technology, and increased focus on improving patient care have resulted in the high growth of the Asia Pacific medical filtration market.

HIGHEST CAGR MARKET IN 2023
INDIA FASTEST GROWING MARKET IN THE REGION
Medical Filtration Market

Recent Developments of Medical Filtration Market

  • In September 2024, Sartorius AG launched Vivaflow SU, setting a new standard in tangential flow filtration (TFF) for laboratories.
  • In April 2024, 3M completed the spin-off of its healthcare business, forming Solventum Corporation as an independent company.
  • In May 2023, Cytiva and Pall Corporation’s life sciences business merged under the Cytiva brand.
  • In May 2022, Merck KGaA invested around USD 453 million to expand its membrane and filtration manufacturing in Cork, Ireland.

Key Market Players

KEY PLAYERS IN THE MEDICAL FILTRATION MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Medical Filtration Market?

Scope of the Report

Report Metric Details
Market size available for years 2021-2030
Base Year Considered 2023
Forecast period 2024-2030
Forecast units Units; Value (USD Million)
Segments covered Material, Process Technology, Design/Process, Application and End-Users
Geographies covered Asia Pacific, North America, Europe, Middle East & Africa, and South America

 

 

Key Questions Addressed by the Report

What is the current size of the global medical filtration market?
The global medical filtration market is estimated to reach USD 9.35 billion by 2030 from USD 6.29 billion in 2024, at a CAGR of 6.8% during the forecast period.
Who are the key players in the global medical filtration market?
Merck KGaA (Germany), 3M (Solventum) (US), Danaher (US), Sartorius AG (Germany), Veolia (France), Thermo Fisher Scientific Inc. (US), Donaldson Company Inc. (US), Baxter (US), Parker Hannifin Corp. (US), Entegris (US), Asahi Kasei Corporation (Japan), and MANN+HUMMEL (Germany) are the key players in this market. They have the potential to broaden their product portfolio and compete with other key market players.
What are some of the drivers for the market growth?
Key drivers for the medical filtration market include the growing demand for high-quality filtration solutions and the growing focus on infection control.
What are the different materials used in medical filtrations?
PES, PVDF, PTFE, and PP are widely used in this market.
What are the major end-use industries of medical filtration?
Hospitals, diagnostics centers, and research institutes are the main end-users in this market.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Medical Filtration Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
32
RESEARCH METHODOLOGY
36
EXECUTIVE SUMMARY
46
PREMIUM INSIGHTS
50
MARKET OVERVIEW
53
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing demand for advanced healthcare solutions
    - Rising awareness of infection control
    - Technological advancements
    RESTRAINTS
    - High capital investments
    - Stringent regulatory compliance
    OPPORTUNITIES
    - Growing healthcare investments in emerging economies
    - Adoption of single-use technologies
    CHALLENGES
    - Speed and yield issues
  • 5.3 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    QUALITY
    SERVICE
  • 5.5 MACROECONOMIC OUTLOOK
    GDP TRENDS AND FORECASTS
  • 5.6 IMPACT OF AI/GEN AI
  • 5.7 VALUE CHAIN ANALYSIS
    RAW MATERIAL SUPPLIERS
    MANUFACTURERS
    DISTRIBUTORS
    END USERS
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 CASE STUDY ANALYSIS
    VALIDATING PEGASUS PRIME VIRUS REMOVAL FILTERS WITH PREFILTERS
    ENHANCING DIALYSIS FILTRATION EFFICIENCY – FRESENIUS MEDICAL CARE
    BLOOD FILTRATION FOR SEPSIS TREATMENT – CYTOSORBENTS CORPORATION
  • 5.10 TARIFF AND REGULATORY LANDSCAPE
    ENVIRONMENTAL REGULATIONS
    NORTH AMERICA
    ASIA PACIFIC
    EUROPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Microfiltration
    - Ultrafiltration
    - Nanofiltration
    COMPLEMENTARY TECHNOLOGIES
    - Single-use technology
    ADJACENT TECHNOLOGIES
    - Chromatography
  • 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.13 TRADE ANALYSIS
    EXPORT SCENARIO (HS CODE 8421)
    IMPORT SCENARIO (HS CODE 8421)
  • 5.14 KEY CONFERENCES AND EVENTS, 2025–2026
  • 5.15 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND, BY REGION, 2021–2023
    AVERAGE SELLING PRICE TREND, BY APPLICATION, 2021–2023
    AVERAGE SELLING PRICE TREND, BY END USER, 2021–2023
  • 5.16 INVESTMENT AND FUNDING SCENARIO
  • 5.17 PATENT ANALYSIS
    INTRODUCTION
    LEGAL STATUS OF PATENTS
    JURISDICTION ANALYSIS
MEDICAL FILTRATION MARKET, BY MATERIAL
87
  • 6.1 INTRODUCTION
  • 6.2 POLYSULFONE & POLYETHERSULFONE
    EXCELLENT MECHANICAL STRENGTH, THERMAL STABILITY, AND CHEMICAL RESISTANCE TO BOOST MARKET
  • 6.3 POLYVINYLIDENE FLUORIDE
    EXCEPTIONAL CHEMICAL RESISTANCE, THERMAL STABILITY, AND MECHANICAL STRENGTH TO DRIVE MARKET
  • 6.4 POLYTETRAFLUOROETHYLENE
    SUPERIOR FILTRATION PERFORMANCE IN CRITICAL MEDICAL APPLICATIONS TO PROPEL DEMAND
  • 6.5 POLYPROPYLENE
    EXCELLENT CHEMICAL RESISTANCE, DURABILITY, AND COST-EFFECTIVENESS TO DRIVE DEMAND
  • 6.6 OTHER MATERIALS
MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY
93
  • 7.1 INTRODUCTION
  • 7.2 ULTRAFILTRATION
    INCREASING PREVALENCE OF CHRONIC KIDNEY DISEASE AND RISING DEMAND FOR DIALYSIS TREATMENTS TO BOOST MARKET
  • 7.3 MICROFILTRATION
    GROWING USAGE IN STERILIZATION, WATER PURIFICATION, AND BIOPHARMACEUTICAL MANUFACTURING TO DRIVE DEMAND
  • 7.4 NANOFILTRATION
    LOW ENERGY CONSUMPTION AND HIGH FILTRATION EFFICIENCY TO SUPPORT MARKET GROWTH
  • 7.5 REVERSE OSMOSIS
    CRUCIAL ROLE IN ENSURING SAFETY OF WATER IN MEDICAL PROCEDURES TO BOOST MARKET
  • 7.6 GAS FILTRATION
    DELIVERY OF HIGH-QUALITY FILTERED AIR TO FUEL GROWTH
  • 7.7 OTHER PROCESS TECHNOLOGIES
MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS
99
  • 8.1 INTRODUCTION
  • 8.2 SYSTEMS (RTU UNITS)
    CONVENIENCE, TIME-SAVING BENEFITS, AND ABILITY TO ENSURE CONSISTENT FILTRATION PERFORMANCE TO BOOST MARKET
  • 8.3 FILTRATION MODULES (CONSUMABLES)
    RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND FOR FILTRATION MODULES IN HEALTHCARE
  • 8.4 OTHER DESIGNS/PROCESSES
MEDICAL FILTRATION MARKET, BY END USER
103
  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    REQUIREMENT OF HIGH-PURITY WATER FOR WOUND CARE, SURGICAL PROCEDURES, STERILIZATION, AND DIALYSIS TO DRIVE MARKET
  • 9.3 DIAGNOSTIC CENTERS
    DEMAND FOR HIGH-PURITY WATER, FLUIDS, AND AIR TO ENSURE RELIABLE DIAGNOSTICS TO DRIVE GROWTH
  • 9.4 RESEARCH INSTITUTES
    INCREASE IN BIOLOGICAL STUDIES, AND MEDICAL RESEARCH TO BOOST MARKET
  • 9.5 OTHER END USERS
MEDICAL FILTRATION MARKET, BY APPLICATION
108
  • 10.1 INTRODUCTION
  • 10.2 DIALYSIS
    ACCURACY AND OPERATIONAL FILTRATION EFFICIENCY IN BLOOD PURIFICATION TO BOOST GROWTH
  • 10.3 DRUG DELIVERY
    PROVISION OF OPTIMAL CONDITIONS THROUGH CONSISTENT FLOW RATES AND MINIMUM PRESSURE DROPS TO FUEL MARKET GROWTH
  • 10.4 IV INFUSION & STERILE FILTRATION
    HIGH LEVEL OF PRECISION IN CONTAMINANT REMOVAL WHILE PRESERVING FLUID INTEGRITY TO DRIVE GROWTH
  • 10.5 ENDOSCOPY
    ENHANCEMENT OF SAFETY AND PERFORMANCE WITH ADVANCED FILTRATION TO BOOST MARKET
  • 10.6 STERILE PROCESSING
    GROWING DEMAND FOR SURGICAL INSTRUMENTS, ENDOSCOPES, AND REUSABLE MEDICAL DEVICES TO PROPEL MARKET
  • 10.7 BIO-ARTIFICIAL PROCESSES
    VITAL ROLE OF SOPHISTICATED FILTRATION SYSTEMS IN DEVELOPMENT AND FUNCTIONALITY OF BIO-ARTIFICIAL ORGANS TO BOOST MARKET
  • 10.8 OTHER APPLICATIONS
MEDICAL FILTRATION MARKET, BY REGION
115
  • 11.1 INTRODUCTION
  • 11.2 ASIA PACIFIC
    CHINA
    - Strong economic growth and expanding healthcare sector to drive market
    JAPAN
    - Growing aging population to propel market
    INDIA
    - Increasing investments in healthcare sector to drive market
    SOUTH KOREA
    - Rising demand for high-quality medical filtration solutions to drive market
    REST OF ASIA PACIFIC
  • 11.3 EUROPE
    GERMANY
    - Economic strength, increasing healthcare expenditure, and rapidly aging population to drive market
    UK
    - Rising geriatric population to support market growth
    FRANCE
    - Aging population and enhancement of healthcare system to propel market
    ITALY
    - Growing aging population to increase demand
    SPAIN
    - Rising demand for advanced medical solutions to propel market
    REST OF EUROPE
  • 11.4 NORTH AMERICA
    US
    - Stringent regulatory guidelines and increasing healthcare spending to boost market
    CANADA
    - Growing aging population and significant government investments in healthcare infrastructure to drive market growth
    MEXICO
    - Government initiatives and growth of healthcare sector to drive market
  • 11.5 MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Saudi Arabia
    - Rest of GCC Countries
    SOUTH AFRICA
    - Outbreaks of contagious diseases to drive demand
    REST OF MIDDLE EAST & AFRICA
  • 11.6 SOUTH AMERICA
    BRAZIL
    - Rising healthcare investments and expanding medical infrastructure to propel growth
    ARGENTINA
    - Increasing healthcare expenditure and enhancement of medical infrastructure to drive market
    REST OF SOUTH AMERICA
COMPETITIVE LANDSCAPE
200
  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.3 REVENUE ANALYSIS, 2021–2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.6 PRODUCT COMPARISON
  • 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Region footprint
    - Material footprint
    - Process technology footprint
    - Design/Process footprint
    - Application footprint
    - End user footprint
  • 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 12.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES – MEDICAL FILTRATION EQUIPMENT PROVIDERS
224
  • 13.1 KEY PLAYERS
    MERCK KGAA
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    3M (SOLVENTUM)
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    DANAHER
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    SARTORIUS AG
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    ASAHI KASEI CORPORATION
    - Business overview
    - Products/Solutions/Services offered
    - MnM view
    BAXTER
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products/Solutions/Services offered
    - MnM view
    VEOLIA
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    DONALDSON COMPANY, INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    PARKER HANNIFIN CORP
    - Business overview
    - Products/Solutions/Services offered
    - MnM view
    ENTEGRIS
    - Business overview
    - Products/Solutions/Services offered
    - MnM view
    MANN+HUMMEL
    - Business overview
    - Products/Solutions/Services offered
    - MnM view
  • 13.2 OTHER PLAYERS
    CORNING INCORPORATED
    CRITICAL PROCESS FILTRATION, INC.
    COBETTER
    GRAVER TECHNOLOGIES
    ERTELALSOP
    KASAG SWISS AG
    FILTROX AG
    MEMBRANE SOLUTIONS
    COLE-PARMER INSTRUMENT COMPANY, LLC
    MEISSNER FILTRATION PRODUCTS, INC.
    MEDICAL FILTRATION SOLUTIONS LTD.
    SEFAR AG
    WALKER FILTRATION
    SAINT-GOBAIN
COMPANY PROFILES - AUTOMATED ENDOSCOPE REPROCESSOR PROVIDERS
294
  • 14.1 KEY PLAYERS
    STERIS
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    FORTIVE
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    OLYMPUS CORPORATION
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    ECOLAB
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    GETINGE
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    STEELCOBELIMED (METALL ZUG GROUP)
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    ENDO-TECHNIK W. GRIESAT (CREO)
    - Business overview
    - Products/Solutions/Services offered
    - MnM view
    WASSENBURG MEDICAL B.V. (HOYA CORPORATION)
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
COMPANY PROFILES – DIALYSIS EQUIPMENT PROVIDERS
321
  • 15.1 KEY PLAYERS
    FRESENIUS MEDICAL CARE AG
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    BAXTER
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    DAVITA INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    NIKKISO CO., LTD.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    B. BRAUN SE
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    NIPRO
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    TORAY MEDICAL CO., LTD.
    - Business overview
    - Products/Solutions/Services offered
    MEDIONICS
    - Business overview
    - Products/Solutions/Services offered
APPENDIX
347
  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 CAPITAL HEALTHCARE EXPENDITURE, 2020–2023 (USD MILLION)
  • TABLE 2 HEALTHCARE SPENDING, 2023 (USD MILLION)
  • TABLE 3 MEDICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • TABLE 5 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 6 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2019–2023
  • TABLE 7 ANNUAL GDP PERCENTAGE CHANGE AND PROJECTIONS FOR KEY COUNTRIES, 2024–2029
  • TABLE 8 HEALTH EXPENDITURE AS PERCENTAGE OF GDP, 2019–2022
  • TABLE 9 MEDICAL FILTRATION MARKET: ROLE OF PLAYERS IN ECOSYSTEM
  • TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EXPORT SCENARIO FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 14 IMPORT SCENARIO FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 15 MEDICAL FILTRATION MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
  • TABLE 16 MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT)
  • TABLE 17 MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT)
  • TABLE 18 MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 19 MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION)
  • TABLE 20 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT)
  • TABLE 21 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT)
  • TABLE 22 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 23 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 24 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT)
  • TABLE 25 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT)
  • TABLE 26 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION)
  • TABLE 27 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION)
  • TABLE 28 MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT)
  • TABLE 29 MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT)
  • TABLE 30 MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 31 MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 32 MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 33 MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 34 MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 35 MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 36 MEDICAL FILTRATION MARKET, BY REGION, 2021–2023 (UNIT)
  • TABLE 37 MEDICAL FILTRATION MARKET, BY REGION, 2024–2030 (UNIT)
  • TABLE 38 MEDICAL FILTRATION MARKET, BY REGION, 2021–2023 (USD MILLION)
  • TABLE 39 MEDICAL FILTRATION MARKET, BY REGION, 2024–2030 (USD MILLION)
  • TABLE 40 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT)
  • TABLE 41 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT)
  • TABLE 42 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 43 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 44 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT)
  • TABLE 45 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT)
  • TABLE 46 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT)
  • TABLE 49 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT)
  • TABLE 50 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT)
  • TABLE 53 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT)
  • TABLE 54 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION)
  • TABLE 55 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION)
  • TABLE 56 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT)
  • TABLE 57 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT)
  • TABLE 58 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 61 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 62 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 64 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 65 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 66 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 67 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 68 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 69 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 70 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 71 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 72 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 73 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 74 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 75 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 76 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 77 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 78 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 79 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 80 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 81 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 82 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 83 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 84 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT)
  • TABLE 85 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT)
  • TABLE 86 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 87 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 88 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT)
  • TABLE 89 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT)
  • TABLE 90 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 91 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION)
  • TABLE 92 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT)
  • TABLE 93 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT)
  • TABLE 94 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 95 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 96 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT)
  • TABLE 97 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT)
  • TABLE 98 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION)
  • TABLE 99 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION)
  • TABLE 100 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT)
  • TABLE 101 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT)
  • TABLE 102 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 103 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 104 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 105 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 106 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 107 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 108 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 109 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 110 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 111 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 112 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 113 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 114 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 115 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 116 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 117 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 118 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 119 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 120 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 121 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 122 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 123 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 124 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 125 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 126 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 127 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 128 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 129 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 130 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 131 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 132 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT)
  • TABLE 133 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT)
  • TABLE 134 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 135 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 136 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT)
  • TABLE 137 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT)
  • TABLE 138 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 139 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION)
  • TABLE 140 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT)
  • TABLE 141 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT)
  • TABLE 142 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 143 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 144 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT)
  • TABLE 145 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT)
  • TABLE 146 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION)
  • TABLE 147 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION)
  • TABLE 148 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT)
  • TABLE 149 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT)
  • TABLE 150 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 151 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 152 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 153 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 154 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 155 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 156 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 157 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 158 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 159 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 160 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 161 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 162 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 163 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 164 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 165 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 166 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 167 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 168 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT)
  • TABLE 169 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT)
  • TABLE 170 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 171 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 172 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT)
  • TABLE 173 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT)
  • TABLE 174 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 175 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION)
  • TABLE 176 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT)
  • TABLE 177 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT)
  • TABLE 178 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 180 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT)
  • TABLE 181 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT)
  • TABLE 182 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION)
  • TABLE 183 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION)
  • TABLE 184 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT)
  • TABLE 185 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT)
  • TABLE 186 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 187 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 188 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 189 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 190 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 191 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 192 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 193 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 194 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 195 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 196 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 197 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 198 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 199 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 200 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 201 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 202 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 203 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 204 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 205 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 206 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 207 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 208 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT)
  • TABLE 209 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT)
  • TABLE 210 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 211 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 212 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT)
  • TABLE 213 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT)
  • TABLE 214 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
  • TABLE 215 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION)
  • TABLE 216 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT)
  • TABLE 217 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT)
  • TABLE 218 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 219 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 220 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT)
  • TABLE 221 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT)
  • TABLE 222 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION)
  • TABLE 223 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION)
  • TABLE 224 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT)
  • TABLE 225 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT)
  • TABLE 226 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 227 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 228 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 229 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 230 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 231 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 232 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 233 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 234 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 235 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 236 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 237 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 238 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 239 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 240 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
  • TABLE 241 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
  • TABLE 242 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 243 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 244 MEDICAL FILTRATION MARKET: DEGREE OF COMPETITION
  • TABLE 245 MEDICAL FILTRATION MARKET: REGION FOOTPRINT
  • TABLE 246 MEDICAL FILTRATION MARKET: MATERIAL FOOTPRINT
  • TABLE 247 MEDICAL FILTRATION MARKET: PROCESS TECHNOLOGY FOOTPRINT
  • TABLE 248 MEDICAL FILTRATION MARKET: DESIGN/PROCESS FOOTPRINT
  • TABLE 249 MEDICAL FILTRATION MARKET: APPLICATION FOOTPRINT
  • TABLE 250 MEDICAL FILTRATION MARKET: END USER FOOTPRINT
  • TABLE 251 MEDICAL FILTRATION MARKET: KEY STARTUPS/SMES
  • TABLE 252 MEDICAL FILTRATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 253 MEDICAL FILTRATION MARKET: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
  • TABLE 254 MEDICAL FILTRATION MARKET: DEALS, JANUARY 2019–JANUARY 2025
  • TABLE 255 MEDICAL FILTRATION MARKET: EXPANSIONS, JANUARY 2019–JANUARY 2025
  • TABLE 256 MEDICAL FILTRATION MARKET: OTHER DEVELOPMENTS, JANUARY 2019–JANUARY 2025
  • TABLE 257 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 258 MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 259 MERCK KGAA: EXPANSIONS, JANUARY 2019–JANUARY 2025
  • TABLE 260 3M (SOLVENTUM): COMPANY OVERVIEW
  • TABLE 261 3M (SOLVENTUM): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 262 3M (SOLVENTUM): OTHER DEVELOPMENTS, JANUARY 2019–JANUARY 2025
  • TABLE 263 DANAHER: COMPANY OVERVIEW
  • TABLE 264 DANAHER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 265 DANAHER: DEALS, JANUARY 2019–JANUARY 2025
  • TABLE 266 DANAHER: OTHERS, JANUARY 2019–JANUARY 2025
  • TABLE 267 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 268 SARTORIUS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 269 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
  • TABLE 270 ASAHI KASEI CORPORATION: COMPANY OVERVIEW
  • TABLE 271 ASAHI KASEI CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 272 BAXTER: COMPANY OVERVIEW
  • TABLE 273 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 274 BAXTER: DEALS, JANUARY 2019–JANUARY 2025
  • TABLE 275 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 276 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 277 VEOLIA: COMPANY OVERVIEW
  • TABLE 278 VEOLIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 279 VEOLIA: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
  • TABLE 280 DONALDSON COMPANY, INC.: COMPANY OVERVIEW
  • TABLE 281 DONALDSON COMPANY, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 282 DONALDSON COMPANY, INC.: EXPANSIONS, JANUARY 2019–JANUARY 2025
  • TABLE 283 PARKER HANNIFIN CORP: COMPANY OVERVIEW
  • TABLE 284 PARKER HANNIFIN CORP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 285 ENTEGRIS: COMPANY OVERVIEW
  • TABLE 286 ENTEGRIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 287 MANN+HUMMEL: COMPANY OVERVIEW
  • TABLE 288 MANN+HUMMEL: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 289 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 290 CRITICAL PROCESS FILTRATION, INC.: COMPANY OVERVIEW
  • TABLE 291 COBETTER: COMPANY OVERVIEW
  • TABLE 292 GRAVER TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 293 ERTELALSOP: COMPANY OVERVIEW
  • TABLE 294 KASAG SWISS AG: COMPANY OVERVIEW
  • TABLE 295 FILTROX AG: COMPANY OVERVIEW
  • TABLE 296 MEMBRANE SOLUTIONS: COMPANY OVERVIEW
  • TABLE 297 COLE-PARMER INSTRUMENT COMPANY, LLC: COMPANY OVERVIEW
  • TABLE 298 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW
  • TABLE 299 MEDICAL FILTRATION SOLUTIONS LTD.: COMPANY OVERVIEW
  • TABLE 300 SEFAR AG: COMPANY OVERVIEW
  • TABLE 301 WALKER FILTRATION: COMPANY OVERVIEW
  • TABLE 302 SAINT-GOBAIN: COMPANY OVERVIEW
  • TABLE 303 STERIS: COMPANY OVERVIEW
  • TABLE 304 STERIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 305 STERIS: DEALS, JANUARY 2019–JANUARY 2025
  • TABLE 306 FORTIVE: COMPANY OVERVIEW
  • TABLE 307 FORTIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 308 FORTIVE: DEALS, JANUARY 2019–JANUARY 2025
  • TABLE 309 OLYMPUS CORPORATION: COMPANY OVERVIEW
  • TABLE 310 OLYMPUS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 311 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
  • TABLE 312 ECOLAB: COMPANY OVERVIEW
  • TABLE 313 ECOLAB: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 314 ECOLAB: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
  • TABLE 315 GETINGE: COMPANY OVERVIEW
  • TABLE 316 GETINGE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 317 GETINGE: EXPANSIONS, JANUARY 2019–JANUARY 2025
  • TABLE 318 STEELCOBELIMED (METALL ZUG GROUP): COMPANY OVERVIEW
  • TABLE 319 STEELCOBELIMED (METALL ZUG GROUP): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 320 STEELCOBELIMED (METALL ZUG GROUP): DEALS, JANUARY 2019–JANUARY 2025
  • TABLE 321 ENDO-TECHNIK W. GRIESAT (CREO): COMPANY OVERVIEW
  • TABLE 322 ENDO-TECHNIK W. GRIESAT (CREO): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 323 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): COMPANY OVERVIEW
  • TABLE 324 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 325 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): DEALS, JANUARY 2019–JANUARY 2025
  • TABLE 326 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW
  • TABLE 327 FRESENIUS MEDICAL CARE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 328 FRESENIUS MEDICAL CARE AG: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
  • TABLE 329 FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2019–JANUARY 2025
  • TABLE 330 BAXTER: COMPANY OVERVIEW
  • TABLE 331 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 332 BAXTER: DEALS, JANUARY 2019–JANUARY 2025
  • TABLE 333 DAVITA INC.: COMPANY OVERVIEW
  • TABLE 334 DAVITA INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 335 DAVITA INC.: DEALS, JANUARY 2019–JANUARY 2025
  • TABLE 336 DAVITA INC.: EXPANSIONS, JANUARY 2019–JANUARY 2025
  • TABLE 337 NIKKISO CO., LTD.: COMPANY OVERVIEW
  • TABLE 338 NIKKISO CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 339 NIKKISO CO., LTD.: DEALS, JANUARY 2019–JANUARY 2025
  • TABLE 340 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 341 B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 342 B. BRAUN SE: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
  • TABLE 343 B. BRAUN SE: EXPANSIONS, JANUARY 2019–JANUARY 2025
  • TABLE 344 NIPRO: COMPANY OVERVIEW
  • TABLE 345 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 346 NIPRO: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
  • TABLE 347 TORAY MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 348 TORAY MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 349 MEDIONICS: COMPANY OVERVIEW
  • TABLE 350 MEDIONICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
LIST OF FIGURES
 
  • FIGURE 1 MEDICAL FILTRATION MARKET AND REGIONAL SCOPE
  • FIGURE 2 MEDICAL FILTRATION MARKET: RESEARCH DESIGN
  • FIGURE 3 MEDICAL FILTRATION MARKET: BOTTOM-UP APPROACH
  • FIGURE 4 MEDICAL FILTRATION MARKET: TOP-DOWN APPROACH
  • FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL FILTRATION MARKET (TOP-DOWN APPROACH)
  • FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS: DRIVERS
  • FIGURE 7 MEDICAL FILTRATION MARKET: DATA TRIANGULATION
  • FIGURE 8 POLYSULFONE & POLYETHERSULFONE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 9 DIALYSIS APPLICATION TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 10 HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD
  • FIGURE 12 GROWING FOCUS ON INFECTION CONTROL IN HEALTHCARE SECTOR TO DRIVE MARKET
  • FIGURE 13 POLYSULFONE & POLYETHERSULFONE SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 14 IV INFUSION & STERILE FILTRATION SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 15 HOSPITALS TO BE LARGEST END USER SEGMENT DURING FORECAST PERIOD
  • FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL FILTRATION MARKET
  • FIGURE 18 MEDICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • FIGURE 20 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 21 MEDICAL FILTRATION MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 22 MEDICAL FILTRATION MARKET: ECOSYSTEM
  • FIGURE 23 MEDICAL FILTRATION MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 24 EXPORT DATA FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • FIGURE 25 IMPORT DATA FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • FIGURE 26 AVERAGE SELLING PRICE TREND, BY REGION, 2021–2023 (USD/UNIT)
  • FIGURE 27 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2021–2023 (USD/UNIT)
  • FIGURE 28 AVERAGE SELLING PRICE TREND, BY END USER, 2021–2023 (USD/UNIT)
  • FIGURE 29 INVESTMENT AND FUNDING SCENARIO, 2020–2024 (USD MILLION)
  • FIGURE 30 PATENTS APPLIED AND GRANTED, 2014–2024
  • FIGURE 31 LEGAL STATUS OF PATENTS, 2014–2024
  • FIGURE 32 TOP JURISDICTIONS
  • FIGURE 33 POLYETHERSULFONE & POLYETHERSULFONE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 34 MICROFILTRATION SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 35 FILTRATION MODULES (CONSUMABLES) SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 36 HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 37 DIALYSIS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 38 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 39 ASIA PACIFIC: MEDICAL FILTRATION MARKET SNAPSHOT
  • FIGURE 40 EUROPE: MEDICAL FILTRATION MARKET SNAPSHOT
  • FIGURE 41 NORTH AMERICA: MEDICAL FILTRATION MARKET SNAPSHOT
  • FIGURE 42 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL FILTRATION MARKET BETWEEN 2019 AND 2024
  • FIGURE 43 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN MEDICAL FILTRATION MARKET, 2021–2023
  • FIGURE 44 MARKET SHARE OF KEY COMPANIES IN MEDICAL FILTRATION MARKET, 2023
  • FIGURE 45 VALUATION OF LEADING COMPANIES IN MEDICAL FILTRATION MARKET, 2023
  • FIGURE 46 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL FILTRATION MARKET, 2023
  • FIGURE 47 MEDICAL FILTRATION MARKET: PRODUCT COMPARISON ANALYSIS
  • FIGURE 48 COMPANY EVALUATION MATRIX, KEY PLAYERS, 2023
  • FIGURE 49 MEDICAL FILTRATION MARKET: OVERALL COMPANY FOOTPRINT
  • FIGURE 50 COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2023
  • FIGURE 51 MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 52 3M (SOLVENTUM): COMPANY SNAPSHOT
  • FIGURE 53 DANAHER: COMPANY SNAPSHOT
  • FIGURE 54 SARTORIUS AG: COMPANY SNAPSHOT
  • FIGURE 55 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
  • FIGURE 56 BAXTER: COMPANY SNAPSHOT
  • FIGURE 57 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 58 VEOLIA: COMPANY SNAPSHOT
  • FIGURE 59 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT
  • FIGURE 60 PARKER HANNIFIN CORP: COMPANY SNAPSHOT
  • FIGURE 61 ENTEGRIS: COMPANY SNAPSHOT
  • FIGURE 62 MANN+HUMMEL: COMPANY SNAPSHOT
  • FIGURE 63 STERIS: COMPANY SNAPSHOT
  • FIGURE 64 FORTIVE: COMPANY SNAPSHOT
  • FIGURE 65 OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 66 ECOLAB: COMPANY SNAPSHOT
  • FIGURE 67 GETINGE: COMPANY SNAPSHOT
  • FIGURE 68 STEELCOBELIMED (METALL ZUG GROUP): COMPANY SNAPSHOT
  • FIGURE 69 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT
  • FIGURE 70 BAXTER: COMPANY SNAPSHOT
  • FIGURE 71 DAVITA INC.: COMPANY SNAPSHOT
  • FIGURE 72 NIKKISO CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 73 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 74 NIPRO: COMPANY SNAPSHOT
  • FIGURE 75 TORAY MEDICAL CO., LTD.: COMPANY SNAPSHOT

The study involved four major activities in estimating the market size of the medical filtration market. Exhaustive secondary research was done to collect information on the market, the peer market, and the grandparent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources have been referred to for identifying and collecting information for this study. These secondary sources include annual reports, press releases, investor presentations of companies, white papers, certified publications, trade directories, articles from recognized authors, gold standard and silver standard websites, and databases. Secondary research has been used to obtain key information about the value chain of the industry, monetary chain of the market, the total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, and regional markets. It was also used to obtain information about the key developments from a market-oriented perspective.

Primary Research

The medical filtration market comprises several stakeholders in the value chain, which include manufacturers, and end users. Various primary sources from the supply and demand sides of the medical filtration market have been interviewed to obtain qualitative and quantitative information. The primary interviewees from the demand side include key opinion leaders in industrial sectors. The primary sources from the supply side include manufacturers, associations, and institutions involved in the medical filtration industry. Primary interviews were conducted to gather insights such as market statistics, data of revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to type, material, end-use industry, and region. Stakeholders from the demand side, such as CIOs, CTOs, and CSOs were interviewed to understand the buyer’s perspective on the suppliers, products, component providers, and their current usage of medical filtration and outlook of their business, which will affect the overall market.

The breakdown of profiles of the primary interviewees is illustrated in the figure below:

Medical Filtration Market

Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2022 available in the public domain, product portfolios, and geographical presence.

Other designations include consultants and sales, marketing, and procurement managers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches have been used to estimate and validate the size of the medical filtration market.

  • The key players in the industry have been identified through extensive secondary research.
  • The supply chain of the industry has been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
  • The research includes the study of reports, reviews, and newsletters of the key market players, along with extensive interviews for opinions with leaders such as directors and marketing executives.
Medical Filtration Market

Data Triangulation

After arriving at the total market size from the estimation process, the overall market has been split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all the segments and sub-segments, the data triangulation and market breakdown procedures have been employed, wherever applicable. The data has been triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market size has been validated by using both the top-down and bottom-up approaches and primary interviews. Hence, for every data segment, there have been three sources—top-down approach, bottom-up approach, and expert interviews. The data was assumed correct when the values arrived from the three sources matched.

Market Definition

Medical filtration is the process that separates solid particles from fluids (liquids or gases) with the use of filter media which allows only the fluid to pass through it and retains the solid matter. This process inevitable in the healthcare settings for ensuring purity of air and fluids to enhance patient safety and improve the effectiveness of medical devices and procedures.

Stakeholders

  • Senior Management
  • End User
  • Finance/Procurement Department
  • R&D Department
  • Manufacturers
  • Raw Material Suppliers

Report Objectives

  • To define, describe, and forecast the size of the medical filtration market, in terms of value and volume.
  • To provide detailed information regarding the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market
  • To estimate and forecast the market size based on type, technology, application, end-use industry, and region.
  • To forecast the size of the market with respect to major regions, namely, Europe, North America, Asia Pacific, Middle East & Africa, and South America, along with their key countries
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and their contribution to the overall market
  • To analyze opportunities in the market for stakeholders and provide a competitive landscape of market leaders.
  • To track and analyze recent developments such as expansions, new product launches, partnerships & agreements, and acquisitions in the market.
  • To strategically profile key market players and comprehensively analyze their core competencies.

 

Previous Versions of this Report

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Medical Filtration Market

DMCA.com Protection Status